• Latrunculin B for Actin Dynamics Workflows

  2026-08-16

  Latrunculin B provides a transient, cell-permeable way to test how actin filament assembly shapes cell morphology, trafficking, and infection-related phenotypes. This workflow emphasizes short exposure windows, serum sensitivity, matched vehicle controls, and orthogonal validation so a negative result is not overinterpreted.

• DZNep as a Context-Aware Epigenetic Probe

  2026-08-15

  3-Deazaneplanocin (DZNep) is more than an EZH2-associated compound: it is a context-sensitive perturbation tool linking SAHH inhibition to chromatin and cell-state changes. This guide shows how to design assays that separate biochemical action, epigenetic response, and phenotype.

• FH1 and the Next Generation of Mature Hepatocyte Models

  2026-08-15

  Mature hepatocyte biology is a strategic requirement for translational liver research, not merely a culture-quality metric. This thought-leadership article examines how FH1 (Catalog No. B3700) can support iPS cell differentiation to hepatocytes, interprets albumin, CYP3A4, AFP, and morphology as complementary maturity signals, and explores a cautious conceptual bridge to light-controlled gene regulation without overstating combination evidence.

• Targeting Glutamine Metabolism in Liver Fibrosis

  2026-08-14

  The reference study identifies a metabolic vulnerability in activated hepatic stellate cells (HSCs): glutaminolysis supports their proliferation and fibrogenic activity through glutamate dehydrogenase (GDH). It further shows that reduced SIRT4 expression releases GDH activity, whereas GDH inhibition or modest SIRT4 overexpression suppresses fibrosis, providing a mechanistic rationale for targeting HSC metabolism.

• Topological Stress, rDNA Lesions, and PML Compartments

  2026-08-14

  Urbancokova and colleagues show that topological stress, RNA polymerase I inhibition, and persistent ribosomal DNA double-strand breaks trigger PML-nucleolar associations (PNAs). Their combination of targeted rDNA cleavage, repair-pathway perturbation, and damage-marker imaging provides a framework for studying how unresolved nucleolar lesions are compartmentalized and linked to senescence.

• Curcumin, NLRP3, and Endothelial Pyroptosis

  2026-08-13

  The reference study shows that curcumin protects human umbilical vein endothelial cells from H2O2-induced injury by suppressing NLRP3-associated pyroptosis and partially restoring endothelial functional markers. Its use of caspase-1 and NLRP3 inhibitors strengthens the mechanistic interpretation, while the cell-based design provides a useful framework for studying oxidative endothelial dysfunction.

• Targeted SPP1 Inhibition in Tumor-Associated Myeloid Cells

  2026-08-13

  The reference study introduces a phenotypic screening and targeted delivery strategy for reducing SPP1 expression in tumor-associated macrophages. Its lead compound, CANDI460, lowered SPP1 in vitro and in vivo and produced tumor remissions across murine models, supporting SPP1-high myeloid cells as a therapeutically actionable population.

• CHIR-99021 for hiPSC Corneal Endothelium

  2026-08-12

  Explore how CHIR-99021 (CT99021) can be used as a temporally controlled Wnt signal in hiPSC-to-corneal endothelial differentiation. This article translates a serum-free neural crest intermediate protocol into practical decisions about exposure, controls, and assay interpretation.

• AMD-070 hydrochloride: CXCR4 Research Workflows

  2026-08-12

  Build reproducible CXCR4 trafficking, WHIM, Waldenström macroglobulinemia, and exploratory viral-entry assays with AMD-070 hydrochloride. This guide connects practical dosing and migration workflows with clinically relevant endpoint selection, controls, and troubleshooting.

• PNU 74654: Wnt Signaling Workflow Guide

  2026-08-11

  PNU 74654 is a DMSO-soluble small-molecule probe for time-controlled Wnt/β-catenin signaling inhibition in cellular assays. This guide connects practical stock preparation and pathway readouts with the muscle FAP findings of a landmark study, while clearly separating validated evidence from exploratory cancer and stem cell applications.

• MTT Assay Workflow for Cardiomyocyte Viability

  2026-08-10

  Use MTT to quantify metabolic recovery, cytotoxicity, and treatment timing in cardiomyocyte and mitochondrial-transplantation studies. This workflow combines practical plate-based optimization with the sequential-therapy concept reported for myocardial ischemia-reperfusion injury.

• Bortezomib (PS-341): Proteasome Research Guide

  2026-08-09

  Bortezomib, also called PS-341, is a reversible 20S proteasome inhibitor used in multiple myeloma research, mantle cell lymphoma research, and apoptosis studies. Product data report strong cell-based antiproliferative activity, while current thymic-regeneration evidence supports proteasome inhibition as a research mechanism but does not establish Bortezomib as a thymic-restoration treatment.

• Central Control of Opioid Mechanical Hypersensitivity

  2026-08-08

  Yin et al. identify a lateral parabrachial–hypothalamic–spinal opioid circuit that controls morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. The findings distinguish central mechanisms of mechanical pain from better-established thermal pathways and suggest circuit-level strategies for studying opioid receptor pharmacology and pain modulation.

• Baicalein: Applied Cancer & Inflammation Workflows

  2026-08-07

  Baicalein enables pathway-focused studies of 12-LOX, arachidonic acid metabolism, apoptosis, and inflammatory signaling. This workflow-led guide shows how to formulate the compound, build orthogonal assays, test cancer selectivity, and troubleshoot solubility or combination-study artifacts.

• Dibutyryl-cAMP, sodium salt: Reliable Solutions for cAMP Ass

  2026-08-07

  This scenario-driven guide addresses real laboratory challenges in cell viability and cAMP signaling pathway research, highlighting how Dibutyryl-cAMP, sodium salt (SKU B9001) from APExBIO delivers reproducible, data-backed results. The article provides evidence-based answers on experimental design, protocol optimization, and vendor selection to help scientists achieve consistent, high-sensitivity outcomes.

455 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page